– Positive top line results from the V005 Phase 2/3 trial of the Human Acellular Vessel™ (HAV™) in vascular trauma repair – – BLA for an indication in vascular trauma planned to be filed with the FDA during the current quarter – - Conference call and live webcast at 4:30 p.m. ET today - DURHAM, N.C., Nov. 09, 2023 (GLOBE NEWSWIRE) Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable, bioengineered human tissue at commercial scale, t
Picton Mahoney Asset Management bought a new stake in shares of Alpha Healthcare Acquisition Corp. III (NASDAQ:ALPA – Free Report) during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund bought 567,500 shares of the company’s stock, valued at approximately $5,869,000. A number of […]
Beauty Health (NASDAQ:SKIN – Get Free Report) and Alpha Healthcare Acquisition Corp. III (NASDAQ:ALPA – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, valuation, analyst recommendations, earnings, risk and institutional ownership. Volatility & Risk Beauty […]
Acutus Medical (NASDAQ:AFIB – Get Free Report) and Alpha Healthcare Acquisition Corp. III (NASDAQ:ALPA – Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their earnings, analyst recommendations, profitability, risk, valuation, institutional ownership and dividends. Institutional and Insider Ownership […]
Cowen Investment Management LLC purchased a new stake in shares of Alpha Healthcare Acquisition Corp. III (NASDAQ:ALPA – Free Report) in the first quarter, according to its most recent filing with the SEC. The firm purchased 145,000 shares of the company’s stock, valued at approximately $1,472,000. Cowen Investment Management LLC owned 0.75% of Alpha Healthcare […]